Biomed-Lublin headed for WSE main market
13:29
Medical preparations and pharmaceuticals producer Biomed-Lublin plans to move from the NewConnect market to the main market of the Warsaw Stock Exchange.
The company said on Friday that it has submitted an issue prospectus to the Financial Supervision Authority. It is not planning a new share issue in connection with the transfer.
Biomed-Lublin has been listed on NewConnect since July 2011.
